Treats infections caused by susceptible strains of the designated organisms in the…. ANDA 61905, held by Pharmobedient. Erythromycin Ethylsuccinate.
As of Nov 16, 2026, ANDA 61905 (E.E.S. 400), held by Pharmobedient, was first approved by FDA on Aug 12, 1982, with 16 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of E.E.S. and other antibacterial drugs, E.E.S. should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. E.E.S.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 1982 | Original application | Approved | None posted |
| E.E.S. 400EQ 400MG BASE · tablet;oral | Erythromycin Ethylsuccinate | Discontinued |
| E.E.S. 400EQ 400MG BASE · tablet;oral | Erythromycin Ethylsuccinate | Rx |
| Sep 1, 2015 | Supplement 50Labeling · Standard review | Approved | None posted |
| Oct 31, 2013 | Supplement 49Labeling · Standard review | Approved | |
| Feb 25, 2009 | Supplement 44Labeling | Approved | None posted |
| Feb 25, 2009 | Supplement 45Labeling | Approved | None posted |
| Jul 21, 2006 | Supplement 43Labeling | Approved | None posted |
| Jan 3, 2003 | Supplement 38Manufacturing | Approved | None posted |
| Dec 9, 2002 | Supplement 39Manufacturing | Approved | None posted |
| Dec 9, 2002 | Supplement 40Manufacturing | Approved | None posted |
| Jan 17, 2001 | Supplement 37Labeling | Approved | None posted |
| Nov 16, 2000 | Supplement 35Labeling | Approved | None posted |
| Apr 20, 1998 | Supplement 36Manufacturing | Approved | None posted |
| Jul 29, 1994 | Supplement 33Manufacturing | Approved | None posted |
| Jul 29, 1994 | Supplement 34Labeling | Approved | None posted |
| Aug 18, 1992 | Supplement 31Manufacturing | Approved | None posted |
| Aug 18, 1992 | Supplement 32Labeling | Approved | None posted |
| Apr 3, 1989 | Supplement 28Manufacturing | Approved | None posted |
| Aug 12, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters